Pfizer’s Competitive Grants Program
Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.
Sign-up to receive all GMG announcements, including Request for Proposal (RFP) postings.
| Title |
Grant Type |
Focus Area |
Country
Sort ascending
|
Application Due Date |
|---|---|---|---|---|
Improving Care for Patients with Hodgkin and Non-Hodgkin’s Lymphoma
Release Date:
|
Education | Oncology | USA | |
Sickle Cell Disease (SCD) Fellowship
Release Date:
|
Fellowship | Rare Disease | USA | |
Quality Improvement Grants to Support Development of Cardiac Amyloid Centers
Release Date:
|
Quality Improvement | Rare Disease | USA | |
Increasing Awareness and Understanding of Amyloid Transthyretin Cardiomyopathy (ATTR-CM)
Release Date:
|
Education | Rare Disease | USA | |
|
Release Date:
|
Education | Internal Medicine | USA | |
2024 IM US Headache Medicine Fellowship
Release Date:
|
Fellowship | Internal Medicine | USA | |
Transthyretin Cardiac Amyloidosis Fellowship
Release Date:
|
Fellowship | Rare Disease | USA | |
Reducing Barriers to Optimal Clinical Care in Breast Cancer
Release Date:
|
Quality Improvement | Oncology | Spain | |
Quality Improvement Grants to Improve Identification and Management of Patients with ATTR Amyloidosis
Release Date:
|
Quality Improvement | Rare Disease | Spain | |
Projects for Enhancing Regional Cancer Treatment
Release Date:
Partner: Japanese Society of Clinical Oncology
|
Quality Improvement | Oncology | Japan | |
Develop Young Physicians to Lead the Increase in Preventive Awareness by Vaccination
Release Date:
|
Education | Vaccines | Japan | |
RSV Infection and RSV Maternal Immunization in Area of Obstetrics and Gynecology
Release Date:
|
Education | Vaccines | Japan |
| Title |
Grant Type |
Focus Area |
Country
Sort ascending
|
Application Due Date |
|---|---|---|---|---|
2021 Rheumatology Fellowship
Release Date:
|
Fellowship | Inflammation & Immunology | USA | |
Topical Hemostasis in Minimally Invasive Surgery
Release Date:
|
Education | Hospital | USA | |
Providing Enhanced Medical Support for Patients with Primary Immunodeficiency (PI) Disorders
Release Date:
|
Education | Internal Medicine | USA | |
Emerging Mechanisms of Action in the Treatment of Moderate-to-Severe Alopecia Areata
Release Date:
|
Education | Inflammation & Immunology | USA | |
Artificial Intelligence/Machine Learning Research in Hemophilia
Release Date:
|
Research | Rare Disease | USA | |
Needs Assessment – Early Therapy Management with CDK 4/6 Inhibitors in Metastatic Breast Cancer
Release Date:
|
Education | Oncology | USA | |
2021 Fellowship for Inflammatory Dermatological Diseases
Release Date:
|
Fellowship | Inflammation & Immunology | USA | |
2021 Inflammatory Bowel Disease (IBD) Fellowship
Release Date:
|
Fellowship | Inflammation & Immunology | USA | |
Atopic Dermatitis Patient Education
Release Date:
|
Education | Inflammation & Immunology | USA | |
Adoption of Biosimilars in Oncology
Release Date:
Partner:
The National Comprehensive Cancer Network® (NCCN) |
Research | Oncology | USA | |
Use of Biosimilar Agents in Inflammatory Conditions
Release Date:
|
Education | Inflammation & Immunology | USA | |
Pediatric Endocrinology Fellowship
Release Date:
|
Fellowship | Rare Disease | USA |